GoCo
27 January 2020

Swedish Minister breaks ground on health cluster expansion

The 100,000 sqm expansion of GoCo Health Innovation City is now underway after Sweden’s Minister of Business, Industry, and Innovation broke ground on the first new building on 24 January.  

GoCo Health Innovation City is already home to AstraZeneca, Essity, Wellspect/Dentsply and the novel life science incubator the BioVentureHub. The area adjacent AstraZeneca's R&D faciliity is now under development with 100,000 sqm of space to be added during the next five to eight years.

GoCo's vision is to be Sweden's largest life science cluster and when complete it will have capacity for 350 companies and 7,000 people.  

“It is through collaboration that we can strengthen Sweden's competitiveness and our leadership in innovation, and at the same time meet common societal challenges. The investment in GoCo Health Innovation City will strength our position even further and make the West Sweden region a world-leading health innovation cluster,” said Ibrahim Baylan, Sweden’s Minister of Business, Industry, and Innovation in a statement.

 

An illustration of Fujibio's new building at the GoCo Health Innovation City
An illustration of Fujibio's new building at the GoCo Health Innovation City. Illustration: tmrw.se
 
First tenant signs agreement

The first new building, which should be ready next year, will be a state-of-the-art laboratory of 8,000 sqm for diagnostics development. The building will be tailor-made for new tenant Japanese cancer diagnostics company Fujirebio, which was announced in connection to the ground-breaking ceremony.  

“Our vision is to continue to expand globally. Good partnership and collaboration are the key to innovation and GoCo Health Innovation City is the perfect place for us to establish new partnerships. The concept and the community will also help us to attract new talent, which is another positive benefit for our company. We look forward to growing in Sweden and I hope that our relations with Sweden will be strengthened,” said Goki Ishikawa, President & CEO, Fujirebio Inc. in a statement. 

 

Read more